Emphasis on the early diagnosis of antithyroid drug-induced agranulocytosis: retrospective analysis over 16 years at one Chinese center

[11] Noguchi S(2016)Controversies in the management of Graves’ disease in children J Endocrinol Invest 39 1247-1257

[12] Watanabe N(2014)An update on the medical treatment of Graves’ hyperthyroidism J Endocrinol Invest 37 1041-1048

[13] Narimatsu H(2016)Characteristics of antithyroid drug-induced agranulocytosis in patients with hyperthyroidism: a retrospective analysis of 114 cases in a single institution in China involving 9690 patients referred for radioiodine treatment over 15 years Thyroid 26 627-633

[14] Noh JY(2015)Characteristics of Korean patients with antithyroid drug-induced agranulocytosis: a multicenter study in Korea Endocrinol Metab 30 475-480

[15] Yamaguchi T(2014)Characteristics of agranulocytosis as an adverse effect of antithyroid drugs in the second or later course of treatment Thyroid 24 796-801

[16] Kobayashi K(1994)Antithyroid drug-induced agranulocytosis: clinical experience with ten patients treated at one institution and review of the literature J Endocrinol Invest 17 29-36

[17] Kami M(2012)Sudden onset agranulocytosis and hepatotoxicity after taking methimazole Intern Med 51 2189-2192

[18] Kunii Y(2012)Delayed anithyroid drug-induced agranulocytosis Endocr Pract 18 e69-e72

[19] Mukasa K(1990)Antithyroid drug-induced agranulocytosis. The usefulness of routine white blood cell count monitoring Arch Intern Med 150 621-624

[20] Ito K(1999)Granulocyte colony-stimulating factor (G-CSF) does not improve recovery from antithyroid drug-induced agranulocytosis: a prospective study Thyroid 9 29-31

[11] Noguchi S(2016)Controversies in the management of Graves’ disease in children J Endocrinol Invest 39 1247-1257

[12] Watanabe N(2014)An update on the medical treatment of Graves’ hyperthyroidism J Endocrinol Invest 37 1041-1048

[13] Narimatsu H(2016)Characteristics of antithyroid drug-induced agranulocytosis in patients with hyperthyroidism: a retrospective analysis of 114 cases in a single institution in China involving 9690 patients referred for radioiodine treatment over 15 years Thyroid 26 627-633

[14] Noh JY(2015)Characteristics of Korean patients with antithyroid drug-induced agranulocytosis: a multicenter study in Korea Endocrinol Metab 30 475-480

[15] Yamaguchi T(2014)Characteristics of agranulocytosis as an adverse effect of antithyroid drugs in the second or later course of treatment Thyroid 24 796-801

[16] Kobayashi K(1994)Antithyroid drug-induced agranulocytosis: clinical experience with ten patients treated at one institution and review of the literature J Endocrinol Invest 17 29-36

[17] Kami M(2012)Sudden onset agranulocytosis and hepatotoxicity after taking methimazole Intern Med 51 2189-2192

[18] Kunii Y(2012)Delayed anithyroid drug-induced agranulocytosis Endocr Pract 18 e69-e72

[19] Mukasa K(1990)Antithyroid drug-induced agranulocytosis. The usefulness of routine white blood cell count monitoring Arch Intern Med 150 621-624

[20] Ito K(1999)Granulocyte colony-stimulating factor (G-CSF) does not improve recovery from antithyroid drug-induced agranulocytosis: a prospective study Thyroid 9 29-31